Ontologies of drug discovery and design for neurology, cardiology and oncology

The complex diseases in the field of Neurology, Cardiology and Oncology have the most important impact on our society. The theoretical methods are fast and they involve some efficient tools aimed at discovering new active drugs specially designed for these diseases. The ontology of all the items tha...

Full description

Saved in:
Bibliographic Details
Published inCurrent pharmaceutical design Vol. 16; no. 24; p. 2724
Main Authors Vázquez-Naya, José M, Martínez-Romero, Marcos, Porto-Pazos, Ana B, Novoa, Francisco, Valladares-Ayerbes, Manuel, Pereira, Javier, Munteanu, Cristian R, Dorado, Julián
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2010
Subjects
Cardiovascular Diseases - classification
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - epidemiology
Databases, Protein
Drug Design
Drug Discovery
Humans
Information Services
Molecular Targeted Therapy
Neoplasms - classification
Neoplasms - drug therapy
Neoplasms - epidemiology
Nervous System Diseases - classification
Nervous System Diseases - drug therapy
Nervous System Diseases - epidemiology
Pharmaceutical Preparations - classification
Online AccessGet more information

Cover

More Information
Summary:The complex diseases in the field of Neurology, Cardiology and Oncology have the most important impact on our society. The theoretical methods are fast and they involve some efficient tools aimed at discovering new active drugs specially designed for these diseases. The ontology of all the items that are linked with the molecule metabolism and the treatment of these diseases gives us the possibility to correlate information from different levels and to discover new relationships between complex diseases such as common drug targets and disease patterns. This review presents the ontologies used to process drug discovery and design in the most common complex diseases.
ISSN:1873-4286
DOI:10.2174/138161210792389199